血液からパーキンソン病の超早期兆候を特定 (Early signs of Parkinson’s can be identified in the blood)

ad

2026-01-29 チャルマース工科大学

スウェーデンのチャルマース工科大学の研究チームは、血液検査によってパーキンソン病の極めて早期段階を検出できる可能性を示した。研究では、発症前から体内で変化が生じるタンパク質や生体分子に注目し、血中バイオマーカーの微細な変動を高感度に解析した。その結果、運動障害などの典型的症状が現れる以前に、疾患特有の分子シグナルを捉えられることが明らかになった。パーキンソン病は診断時にはすでに神経変性が進行している場合が多く、治療介入が難しいとされてきた。本成果は、早期診断による進行抑制治療や新薬開発、患者の生活の質向上につながる可能性を示しており、将来的な臨床応用が期待されている。

<関連情報>

パーキンソン病の前駆期と既往期におけるDNA修復シグネチャー軌跡の縦断的評価 Longitudinal assessment of DNA repair signature trajectory in prodromal versus established Parkinson’s disease

Danish Anwer,Nicola Pietro Montaldo,Elva Maria Novoa-del-Toro,Diana Domanska,Hilde Loge Nilsen & Annikka Polster
npj Parkinson’s Disease  Published:05 December 2025
DOI:https://doi.org/10.1038/s41531-025-01194-7

Abstract

Parkinson’s disease (PD) is a progressive neurodegenerative disorder. DNA repair dysfunction and integrated stress response (ISR) dysregulation have been implicated in PD pathophysiology, however, their role during the prodromal phase remains unclear. We analyzed longitudinal blood transcriptomic data from the Parkinson’s Progression Markers Initiative to assess DNA repair and ISR genes in healthy individuals, prodromal PD, and those with established PD. Logistic regression classifiers showed that DNA repair and ISR expression distinguished prodromal PD from healthy individuals, with accuracy peaking in later prodromal stages. In contrast, these pathways did not separate established PD from controls, suggesting a more prominent role early in progression. Gene expression variability in prodromal PD was high at baseline but decreased over time, indicating convergence as disease advances. Notably, 50% of DNA repair genes and 74% of ISR genes showed non-linear patterns, suggesting a transient adaptive response fading with progression. Feature importance analysis highlighted several predictors of prodromal PD, including ERCC6, PRIMPOL, NEIL2, and NTHL1. These findings indicate that DNA repair and ISR dysregulation are relevant in prodromal PD and may be biomarkers for early detection and intervention. Future research should validate these results in larger cohorts and evaluate diagnostic and therapeutic potential.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました